Advertisements

Mycelex Cream

Quick links to important sections

Mycelex Cream

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Mycelex Cream

Quick Facts

Property Description
Active Ingredient Clotrimazole (INN)
Form Cream (Topical)
Pharmacological Class Azole Antifungal Agent
General Purpose To eliminate fungal organisms
Origin Synthetic Compound

Mycelex Cream: Definition and Pharmacological Identity

Mycelex Cream is a specific topical pharmaceutical preparation whose sole active ingredient is Clotrimazole (INN), a synthetically derived chemical compound. The substance is formally classified as an imidazole antifungal, belonging to the larger family of azole antifungal agents. This classification immediately defines the medicine's role: to target and suppress the growth of fungal organisms that cause localized skin infections. As a synthetic drug, Clotrimazole provides a standardized and reliable spectrum of activity against a variety of pathogenic yeasts and dermatophytes. The compound's established efficacy as a broad-spectrum antifungal agent is clinically recognized for its ability to address common dermal fungal issues, which reinforces its trustworthiness for localized applications.

Composition, Form, and General Purpose

The medication is formulated as a cream, a semi-solid emulsion used as a vehicle to deliver the therapeutic substance directly to the skin surface via the topical route of administration. Clotrimazole is a single-ingredient product, dispersed in a typical cream base to ensure optimal contact with the affected dermal layer. The general purpose of this agent is to eliminate the source of fungal outbreaks by directly compromising the integrity of the fungal cell. It achieves this by inhibiting the biosynthesis of ergosterol, which is a critical sterol necessary for the structure and function of the fungal cell membrane. This mechanism provides fungicidal and fungistatic effects, a function commonly leveraged in managing external fungal skin conditions. This necessary action leads to the resolution of the presence of fungal pathogens on the skin.

Advertisements

What side effects are possible with Mycelex Cream?

Possible Side Effects and Safety Information

This section summarizes the adverse reactions and safety characteristics of the active ingredient in Mycelex Cream (Clotrimazole), strictly based on official government regulatory documents.


Adverse Reaction Scope

The most commonly documented adverse reactions primarily affect the skin and subcutaneous tissues at the application site. These are frequently classified as Common in regulatory frameworks, or listed as Frequency Not Defined in post-marketing reports, and include localized sensations and visible effects.

Category Documented Reactions
Local Skin Reactions Burning, stinging, erythema (redness), pruritus (itching), blistering, peeling, irritation
Serious Reactions Hypersensitivity (Allergic Reaction)

Serious adverse reactions are primarily related to the potential for a hypersensitivity or allergic reaction to the active ingredient or excipients. These reactions fall under the Immune System Disorders category and may involve systemic symptoms such as low blood pressure or difficulty breathing.

Safety Considerations and Restrictions

Official regulatory documents contain several constraints for safe use:

  • Ocular Exposure: The cream is not intended for ophthalmic use and should not be applied to the eye.
  • Latex Products: The product may reduce the effectiveness and safety of latex barrier contraceptives, such as condoms and diaphragms, when applied to the genital area.
  • Population Notes: Due to minimal systemic absorption after topical application, no distinct safety differences are generally observed for pediatric or geriatric populations compared to adults. Safety statements regarding pregnancy are informed by this low systemic exposure.

These official safety elements establish that the risks are concentrated at the site of application while mandating specific safety precautions regarding material incompatibility and known hypersensitivity.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation classifies the potential for overdose with topical Clotrimazole (Mycelex Cream) based on its route of administration and low systemic absorption.


Overdose Profile and Risk

Category Official Regulatory Statement
Topical Risk No risk of acute intoxication is seen following a single dermal application of an overdose to the skin, even over a large area.
Systemic Effects Systemic effects are unlikely due to minimal absorption; peak concentrations in the bloodstream are below detection limits.
Primary Manifestations Symptoms are primarily associated with inadvertent oral ingestion, including dizziness, nausea, and vomiting.
Specific Antidote No specific antidote is known for clotrimazole overdose.

Emergency Action Requirements

Urgent medical assistance is mandated in cases of accidental swallowing. If Mycelex Cream is accidentally ingested, an individual must seek immediate emergency medical attention or call the Poison Help line. For severe outcomes, such as passing out or having trouble breathing, emergency services should be contacted immediately.

Management is restricted to symptomatic and supportive treatment. Procedures such as gastric lavage are rarely required and should only be considered by medical professionals if clinical symptoms of overdose become apparent after oral ingestion, provided the airway can be adequately protected. The regulatory classification confirms that the accidental ingestion of the cream is unlikely to lead to a life-threatening situation.

Advertisements

Therapeutic Uses of Mycelex Cream

Mycelex Cream, which contains the agent clotrimazole, is an approved topical preparation intended to manage a range of skin infections caused by fungi. This medication is primarily used in a therapeutic setting to address common conditions known as dermatophytoses.

Quick Facts

  • Helps manage tinea pedis (athlete's foot).
  • Assists in the treatment of tinea cruris (jock itch).
  • Supports the treatment of tinea corporis (ringworm).
  • Is an option for cutaneous candidiasis (yeast infection of the skin).
  • Provides therapeutic support for pityriasis versicolor, a fungal condition that affects skin coloration.

The application of the cream is a component of a comprehensive treatment plan intended to help resolve the symptoms associated with these superficial fungal infections. When utilized as directed, this topical agent may contribute to improvement in skin appearance and comfort.

Advertisements

Eligibility and Restrictions for Use

Official Eligibility Profile: Topical Clotrimazole

The eligibility for using Mycelex Cream (topical Clotrimazole) is defined by regulatory labels based on age, specific conditions, and physiological status.

Scope Eligibility Status (Regulatory Basis)
Populations Contraindicated Individuals with known hypersensitivity to clotrimazole or any component of the cream formulation.
Age-Group Eligibility Children under two years of age should not use the cream unless directed by a healthcare professional. Use is generally permitted for older children, adolescents, and adults.
Pregnancy Eligibility Use during the first trimester is restricted and should occur only if the need is clearly established. Use in the second and third trimesters is generally considered acceptable.
Lactation Status Caution is advised for nursing mothers, although the risk to the infant is considered minimal due to low systemic absorption following topical application.
Condition Restriction The cream is not effective for, and therefore should not be used to treat, onychomycosis (fungal infection of the nail).

Regulatory documentation defines these criteria as absolute contraindications (hypersensitivity) or conditional restrictions (age, first-trimester pregnancy) that determine who is officially permitted to use the medicine under its labeled conditions.

Advertisements

What should I know about interactions with other medicines?

The official regulatory profile for Mycelex Cream (Clotrimazole, topical) is characterized by a minimal risk of systemic drug-drug interactions. Because the medication is applied directly to the skin, absorption into the bloodstream is negligible, leading to no formal systemic contraindications documented in regulatory labeling for co-administered medicines.

A key precautionary note addresses potential Metabolic Pathway Interaction involving the CYP3A4 enzyme. Regulatory documents specify that although systemic exposure is low, there is a potential for Clotrimazole to inhibit the metabolism of certain co-administered drugs that are substrates of this enzyme. Co-administration with systemic immunosuppressants, such as Tacrolimus and Sirolimus, may result in increased plasma concentrations of those medicines. This is officially documented as an exposure-modifying pharmacokinetic interaction requiring caution.

A separate, non-medicinal interaction is also explicitly noted: a Material Degradation Risk. The cream has been shown in laboratory tests to cause damage to latex products, including condoms and diaphragms, which could compromise their barrier integrity and effectiveness. Regulatory guidance therefore includes a constraint to avoid concurrent use of the cream in the genital area with these latex-containing barrier contraceptives. No mandatory time separation rules are documented for co-administering other medicines, and no explicit interactions with food, alcohol, or supplements are listed in the official interaction profile.

Advertisements

Mechanism of Action

The mechanism of action of Clotrimazole is confined to the fungal organism, operating through targeted biochemical interference to disrupt the structural integrity of the fungal cell.

Blocking the Ergosterol Biosynthesis Pathway

The drug’s core mechanism is the inhibition of the fungal enzyme lanosterol 14-alpha-demethylase (CYP51). By blocking this enzyme, the metabolic pathway that produces ergosterol—the essential structural component of the fungal cell membrane—is disrupted, while toxic methylated sterols accumulate.

Causing Fungal Cell Lysis

The lack of ergosterol and the accumulation of toxic precursors lead to a fundamentally unstable and compromised fungal cell membrane. This damage increases the membrane's permeability, causing the critical loss of intracellular components, which rapidly precipitates the death and lysis of the fungal cell itself. This process ultimately leads to the irreversible structural and functional failure of the fungal cell.

Advertisements

Dosage and Administration Information

How to Use Mycelex Cream: Official Administration Guidelines

The administration of Mycelex Cream, which contains the antifungal agent clotrimazole, is intended for topical use on the skin only. The medication is formulated as a 1% cream, and its usage follows a defined procedural structure detailed in prescribing information.


Core Administration Principles

Entity Official Administration Guideline
Route of Administration Dermal (Topical).
Frequency Twice daily (typically morning and evening).
Dosing Quantity Apply a thin film of the cream sufficient to cover the entire affected area and the immediate surrounding skin.

Procedural Structure and Duration

Official instructions stipulate that the area receiving treatment should be washed and thoroughly dried before application of the cream. The recommended procedure involves gently massaging the cream into the skin until it is no longer visible on the surface. Treatment should be continued for the full duration specified for the condition being addressed, even if improvement is noted early.

  • Duration Patterns: Course durations vary by specific infection: typically 2 to 4 weeks for cutaneous candidiasis and ringworm, 2 weeks for jock itch, and 4 to 8 weeks for athlete’s foot.
  • Procedural Constraints: The cream must not be used near the eyes (ophthalmically) or in the mouth. Furthermore, its application generally mandates avoiding occlusive dressings or wrappings over the treated area unless specifically advised by a physician.

These directions establish a standardized protocol for the proper delivery and duration of the topical therapy, ensuring adherence to the intended use.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Mycelex Cream

Evidence for Use in Dermatophytoses (Ringworm, Athlete's Foot, and Jock Itch)

The research exploring this cream's application for common fungal infections includes Randomized Controlled Trials (RCTs). Systematic reviews have aggregated these studies to explore outcomes related to physical discomfort—such as itching and scaling. Studies monitored mycological clearance, which is the laboratory confirmation of the absence of fungal organisms. Research describes studies where the cream was observed in comparison to a non-active agent (placebo) or other similar antifungal products. Findings describe patterns observed in the studies related to clearance rates, and research provides context on how symptoms were measured. However, the quality of the evidence varies across studies, and findings were sometimes mixed, as the evidence base is often described as heterogeneous (variable in design), making it challenging to draw uniform conclusions across all available data.

Research Findings for Cutaneous Candidiasis (Yeast Infections of the Skin)

The evidence supporting the cream's use for skin yeast infections was evaluated in clinical trials, including comparisons against non-active agents. These studies primarily focused on monitoring physiological strain or stress and mycological clearance. Studies that included non-active controls measured outcomes across the comparison groups. The reported outcomes reflect the short-term changes observed during the two-to-four-week treatment course. What remains uncertain is the full comparative picture, as comparative evidence is lacking against some newer generations of topical antifungal treatments.


Long-Term Evidence and Known Uncertainties

Research has primarily focused on achieving clearance within the treatment phase, meaning follow-up durations were limited. The majority of reported outcomes involved short-term follow-up, with assessments taken shortly after the conclusion of the treatment period of a few weeks. Consequently, there is limited information for long-term outcomes tracking patients over several months to determine the frequency of recurrence. The long-term pattern of measurements recorded in the studies is not well characterized.

Clinical studies generally focused on broad groups of adult patients. While older adult populations were observed in some studies, the research does not determine whether the same outcomes will be measured across all age groups. The data for certain groups remain insufficient, which indicates the results apply only to the populations studied in the original clinical trials.

Key Studies & References Clotrimazole Cream USP 1% Label: Official Indications and Clinical Information Summary (DailyMed, NIH)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Mycelex Cream (FAQ)

Q: Is Mycelex Cream available over the counter?

A: Topical products containing clotrimazole, the active ingredient in Mycelex Cream, are generally classified by regulatory authorities as available for both over-the-counter (OTC) use and by prescription. This indicates that certain formulations or strengths may be accessible without a prescription.


Q: Do I need a prescription for Mycelex Cream?

A: Clotrimazole products are available in forms that can be purchased over-the-counter (OTC) and in formulations that require a prescription. Whether a prescription is needed depends on the specific product, its strength, and where it is sold.


Q: How long does it typically take for Mycelex Cream to start working?

A: Official clinical documents describe that patients often begin to notice improvement in symptoms, particularly relief of itching (pruritus), within the first week of treatment. Official guidance emphasizes the need to continue the full treatment duration as specified, even after symptoms improve.


Q: Is there a generic version of Mycelex Cream available?

A: Yes, the active ingredient in Mycelex Cream is clotrimazole, which is widely available in lower-cost generic versions. These generic formulations contain the same active ingredient as the brand-name product.


Q: Can Mycelex Cream interact with blood thinners?

A: Official labeling notes that clotrimazole has the potential to affect the metabolism of certain co-administered drugs that are processed by the CYP3A4 enzyme. Some blood thinners are known to be substrates of this enzyme. Official sources suggest that this mechanism may result in increased blood levels of the co-administered medicine.


Q: Is Mycelex Cream suitable for use by children?

A: Official labeling generally advises against using the cream in children under two years of age unless specifically directed by a healthcare provider. Official documentation describes that use for children aged two years and older is generally acceptable.


Q: Is Mycelex Cream generally appropriate for use during pregnancy?

A: Use of the cream during the first trimester of pregnancy is restricted and should only occur if the need is clearly established. Use in the second and third trimesters is generally considered acceptable. This is primarily informed by the low systemic absorption that occurs after topical application.


Q: Is there any information about using Mycelex Cream while breastfeeding?

A: Caution is advised for nursing mothers due to a lack of sufficient human studies on this topic. However, the risk to the infant is described as minimal because of the low amount of active ingredient absorbed into the body following topical use of the cream.


Q: Can people with liver conditions use Mycelex Cream?

A: Regulatory-referenced information notes that abnormal liver function tests (LFTs) have been reported with clotrimazole use. While topical absorption is low, some authorities note that periodic monitoring of LFTs (liver function tests) is described in some guidance for patients who have pre-existing hepatic impairment.


Q: What population groups have been included in studies for Mycelex Cream?

A: Clinical studies supporting the cream’s use generally focused on broad groups of adult patients. While older adult populations were observed in some of these studies, official research documents describe the data for certain patient groups as insufficient to draw universal conclusions.


Q: What is the research evidence for Mycelex Cream primarily based on?

A: The research evidence used to establish the cream’s profile is primarily based on Randomized Controlled Trials (RCTs) and systematic reviews. These studies examined key outcomes such as mycological clearance (the absence of the fungus) and relief of physical discomfort, like itching and scaling.


Q: Is it possible to be allergic to Mycelex Cream?

A: Yes. Serious adverse reactions are principally related to the potential for hypersensitivity or an allergic reaction. Hypersensitivity to the active ingredient or other components of the cream is officially listed as a contraindication to its use.


Q: Can Mycelex Cream stain clothing or fabric?

A: While the focus of official US warnings is on the potential fire hazard of fabric that has contacted the cream, external patient medication information notes that the cream may protect clothing and fabrics from staining. Patients are advised to be aware of the official fire hazard warning associated with fabric that has contacted the cream.


Q: What is the official purpose of the inactive ingredients in Mycelex Cream?

A: The inactive ingredients, which may include components like cetostearyl alcohol, are dispersed in a vanishing cream base. Their official purpose is to serve as the vehicle, ensuring the active therapeutic substance is effectively delivered and absorbed into the skin surface where it is needed.


Q: Does Mycelex Cream have a strong smell?

A: The active ingredient in the cream, clotrimazole, is officially described by regulatory-linked sources as an odorless, white crystalline substance. Therefore, the product is not associated with a strong odor.


Q: How is Mycelex Cream different from a powder form of the same drug?

A: The cream is described as a semi-solid emulsion used as a vehicle to deliver the substance directly to the skin surface. Powder formulations, in contrast, are generally intended by official labeling for application to larger areas of the body or areas with hair.


Q: Are there different names for Mycelex Cream in other countries?

A: Yes, products containing the active ingredient clotrimazole are marketed under a wide variety of different brand names internationally. The naming conventions vary depending on the regulatory region.


Q: Is Mycelex Cream approved for treating every type of fungal infection?

A: No. Official documents state that the cream is not effective for, and therefore should not be used to treat, onychomycosis, which is a fungal infection of the nail. It is also not effective on the scalp.


Q: Why would a doctor prescribe Mycelex Cream over a pill form of antifungal?

A: The topical cream is generally recommended for localized fungal skin infections because it demonstrates poor absorption into the bloodstream. This property is linked to a minimized risk of systemic side effects and potential drug interactions, which are typically associated with oral (pill) forms.


Q: Are there official restrictions on how long Mycelex Cream can be used continuously?

A: Official guidance describes typical treatment courses lasting between two and four weeks. There is advice against using the cream for more than four continuous weeks unless under the direction of a healthcare professional, as prolonged use may be associated with the risk of resistance.


Q: Can I use Mycelex Cream for athlete's foot?

A: Yes, regulatory documents and official monographs state that topical clotrimazole products are generally recognized as safe and effective for the treatment of tinea pedis, commonly known as athlete's foot.


Q: Does Mycelex Cream help with yeast infections?

A: Yes, official labeling confirms that clotrimazole cream is indicated for the topical treatment of candidiasis due to Candida albicans, which is a common type of yeast infection that affects the skin.


Q: Can Mycelex Cream be used for jock itch?

A: Yes, official regulatory documents state that topical clotrimazole products are generally recognized as safe and effective for the treatment of tinea cruris, commonly known as jock itch.


Q: Are there any reported drug interactions with Mycelex Cream?

A: Yes, regulatory documents note an interaction risk with certain immunosuppressants like Tacrolimus and Sirolimus. This is due to the potential of clotrimazole to inhibit the CYP3A4 enzyme, which could lead to increased blood levels of these co-administered medicines.

Advertisements

How should Mycelex Cream be stored and disposed of?

Official Storage and Disposal Guidelines

Regulatory agencies specify mandatory conditions for the storage and disposal of Mycelex Cream (Clotrimazole) to maintain product integrity and safety.

Storage Requirement Official Status
Temperature Store at controlled room temperature, typically 20 C to 25 C (not above 30 C).
Prohibited Conditions Do not freeze or expose to excessive heat, moisture, or direct light.
Container Rule Keep the medication in its original container, tightly closed, until the expiration date.
Child Safety Mandatory to keep the cream out of the sight and reach of children.
Handling Warning Fabric (such as bedding or clothing) that has contacted the cream is a serious fire hazard and should be kept away from naked flames.

Disposal must adhere to strict environmental rules. Do not dispose of unused or expired Mycelex Cream by flushing it down a toilet or pouring it into a drain. The proper method is to ask a pharmacist about local medication take-back or disposal programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Mycelex Cream found in:

A-Z Index: